The individual's healthcare in the last 12 months of life costs about 25% of total healthcare costs for that person's life. Should policy makers’ better control end-of-life costs? This is just one of many questions addressed in this segment about weighing the effectiveness of treatment vs. cost. Join us as host Dr. Bill Rutenberg interviews Senior Medical Economist of the Rand Corporation, Geoffrey Joyce PhD.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Health Policy: Weighing Treatment Effectiveness vs. Cost
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
The individual's healthcare in the last 12 months of life costs about 25% of total healthcare costs for that person's life. Should policy makers’ better control end-of-life costs? This is just one of many questions addressed in this segment about weighing the effectiveness of treatment vs. cost. Join us as host Dr. Bill Rutenberg interviews Senior Medical Economist of the Rand Corporation, Geoffrey Joyce PhD.
Presenters
Facebook Comments